Preclinical profile of the pyrimidinylpiperazinyl imide compound WY-47,846: A potential anxiolytic
- 1 January 1989
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 18 (1), 29-45
- https://doi.org/10.1002/ddr.430180105
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Buspirone decreases the activity of 5-hydroxytryptamine-containing dorsal raphe neurons in-vitroJournal of Pharmacy and Pharmacology, 1986
- 1-(2-Pyrimidinyl)-Piperazine as Active Metabolite of Buspirone in Man and RatPharmacology, 1986
- Behavioral and neurochemical studies on the anticonflict actions of buspironeDrug Development Research, 1984
- Benzodiazepines attenuate single unit activity in the locus coeruleusLife Sciences, 1980
- Long-Term Antidepressant Treatment Decreases Spiroperidol-Labeled Serotonin Receptor BindingScience, 1980
- Molecular Mechanisms in the Receptor Action of BenzodiazepinesAnnual Review of Pharmacology and Toxicology, 1979
- New concepts on the mechanism of action of benzodiazepinesLife Sciences, 1975
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- Effects of Amphetamine on Single Cell Activity in a Catecholamine Nucleus, the Locus CoeruleusNature, 1971
- The effects of meprobamate, barbiturates, d-amphetamine and promazine on experimentally induced conflict in the ratPsychopharmacology, 1960